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Abstract
Objective: To conduct a meta-analysis of all published genetic association studies of 5-HTTLPR polymorphisms performed in
PTSD cases
Methods Data Sources: Potential studies were identified through PubMed/MEDLINE, EMBASE, Web of Science databases
(Web of Knowledge, WoK), PsychINFO, PsychArticles and HuGeNet (Human Genome Epidemiology Network) up until
December 2011. Study Selection: Published observational studies reporting genotype or allele frequencies of this genetic
factor in PTSD cases and in non-PTSD controls were all considered eligible for inclusion in this systematic review. Data
Extraction: Two reviewers selected studies for possible inclusion and extracted data independently following a standardized
protocol. Statistical analysis: A biallelic and a triallelic meta-analysis, including the total S and S’ frequencies, the dominant
(S+/LL and S’+/L’L’) and the recessive model (SS/L+ and S’S’/L’+), was performed with a random-effect model to calculate the
pooled OR and its corresponding 95% CI. Forest plots and Cochran’s Q-Statistic and I2 index were calculated to check for
heterogeneity. Subgroup analyses and meta-regression were carried out to analyze potential moderators. Publication bias
and quality of reporting were also analyzed.
Results: 13 studies met our inclusion criteria, providing a total sample of 1874 patients with PTSD and 7785 controls in the
biallelic meta-analyses and 627 and 3524, respectively, in the triallelic. None of the meta-analyses showed evidence of an
association between 5-HTTLPR and PTSD but several characteristics (exposure to the same principal stressor for PTSD cases
and controls, adjustment for potential confounding variables, blind assessment, study design, type of PTSD, ethnic
distribution and Total Quality Score) influenced the results in subgroup analyses and meta-regression. There was no
evidence of potential publication bias.
Conclusions: Current evidence does not support a direct effect of 5-HTTLPR polymorphisms on PTSD. Further analyses of
gene-environment interactions, epigenetic modulation and new studies with large samples and/or meta-analyses are
required.
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Background
Post-traumatic stress disorder (PTSD) is a mental disorder that
occurs following exposure to a potentially traumatic life event
(Criterion A) and is characterized by symptoms of re-experience,
avoidance, dulling of the senses and hyperarousal. Those who
develop PTSD are at substantially increased risk of unemploy-
ment, marital instability and health problems (major depression,
substance dependence, impaired role functioning and reduced life
course opportunities) [1]. Therefore, PTSD constitutes a potential
major health care burden. However, while trauma exposure rates
vary between 40–80% over the course of the life of individuals,
only a percentage of those exposed to traumatic events (25%
approximately) will develop PTSD [2].
Recent data indicate that both the risk of trauma exposure and
PTSD may be influenced by genetic factors [3,4]. The evidence
for genetic influences on risk for PTSD comes from a diversity of
family, twin and molecular genetic studies. An elevated risk of
PTSD among relatives with PTSD and a heritability of almost
30% suggest that genes are important risk factors in the etiology of
the disorder. Molecular genetic studies using case-control candi-
date gene-association designs have shown a variety of results.
Several candidate genes related to the current understanding of
the neurobiology of the disorder have been studied [3]. The most
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frequently investigated genetic variant recently studied is the role
of the human serotonin transporter (5-hydroxytryptamine transporter, 5-
HTT) gene (SLC6A4), through polymorphisms in its promoter
region. The importance of this gene is primarily due to the
increasing evidence of its role in modulating sensitivity to stress
and vulnerability to psychopathology [5]. The promoter activity of
the 5-HTT gene, located at 17q11.1-q12, is modified by sequential
elements within the proximal 5 regulatory region, designated the
5-HTT gene-linked polymorphic region (5-HTTLPR) [6]. The less
frequent short (S) allele in the 5-HTTLPR is associated with lower
transcriptional efficiency of the promoter compared with the more
frequent long (L) allele [7] and has been related to suicidal
behavior [8], depression [9], neurotic personality trait [7,10],
alcoholism [11] and PTSD [12].
Other 5-HTTLPR variants have been described in a Japanese
study [13] showing a third functional allele, LG, with an A.G
polymorphism at position 6 of the first two 22-bp imperfect repeats
that define the 16-repeat L allele (SNP rs25531). This LG is
equivalent in expression to the S allele [11]. Thus, 5-HTTLPR is a
triallelic locus with alleles designated as LG, LA, and S and the three
of them appear to act codominantly [11]. Because the LG and S
alleles have comparable levels of serotonin transporter expression,
both of which are lower than that of LA, a novel approach has been
used with a reclassification of the alleles on the basis of lower and
higher levels of expression [14,15]. This approach reclassified LG
and S as S’ and LA as L’.
Differences in ethnic distribution have been described with a
higher frequency of the long variant allele (L) in Europeans (57%;
95% CI: 49.9–61.8%) than in Asians (27%; 95% CI: 23.9–32.9%)
[8] and a different distribution of the triallelic classification
between Afro-American adults (L’L’: 34.8%; S’L’: 47.8%; and S’S’:
17.4%) and European-Americans (L’L’: 25.1%; S’L’: 54.9%; and
S’S’: 20.0%) [16]. The allelic frequency of LG is 0.09–0.14 in
Caucasians and 0.24 in Afro-Americans [11].
Two studies have reported an association of PTSD with the SS
genotype [17,18] and a third [19] reported a significant association
with the LALA but not with the SS genotype. Other studies
[12,16,19–21] have not found a direct link between the 5-
HTTLPR genotype and the risk of PTSD but have reported a
gene-environment (GxE) interaction whereby the genetic effect of
5-HTTLPR is modified by the level of trauma exposure [4,22]. Of
the five studies that analyzed a potential GxE interaction, four
found a significant interaction with the low-expression genotype
[12,16,17,19,20] and another [19] found a significant interaction
but with the LALA genotype. These inconsistencies in the published
findings of genetic association studies of 5-HTTLPR and PTSD
might be the result of several factors that need to be systematically
assessed, including different designs, statistical power and quality
characteristics of primary studies.
Although previous reviews of the genetic factors involved in
PTSD have been published [3,4,22,23], none of them can be
considered a systematic review and no meta-analysis has been
conducted [24]. The main aim of the current study was to perform
a systematic review and a meta-analysis of all available genetic
association studies of 5-HTTLPR polymorphisms in PTSD and to
determine if the S allele or SS genotype increases the risk of PTSD
in those exposed to a traumatic experience compared to the L
allele or LL genotype. A secondary aim of this meta-analysis was to
compare the association between the genotype using the biallelic
and the triallelic models and to assess if the latter better captures
the effect of the 5-HTTLPR variation on PTSD.
Methods
Search strategy
Potential published studies were identified through PubMed/
MEDLINE, EMBASE, Web of Science databases (Web of
Knowledge, WoK), PsychINFO, PsychArticles and HuGeNet
(Human Genome Epidemiology Network) using the search terms:
‘‘[PTSD OR posttraumatic stress disorder OR trauma*
stress] AND [5-HTTLPR OR 5-HTT OR SLC6A4 OR
SERTPR OR Serotonin Transporter Gene]’’ up until
December 2011. The reference lists of original studies and review
articles included were manually searched to identify other
potentially eligible studies. In addition, the MEDLINE option
R`elated Articles` was used for the same purpose. To minimize
potential publication bias, no restrictions were placed on time
period, sample size, population and language of publication or
type of report.
Inclusion and exclusion criteria
Published observational studies (criterion 1) reporting genotype
or allele frequencies of the genetic factor (criterion 2) in PTSD
cases and in non-PTSD controls (criterion 3) were all considered
eligible for inclusion in this systematic review. Case status was
defined as having a current or one-year DSM-III, DSM-IIIR or
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders)
diagnosis of PTSD assessed by established psychiatric interviews.
Studies of all ethnic groups were considered eligible. Reviews,
case-only studies, family-based designs and population studies with
only healthy subjects were excluded, as well as other studies
describing genetic effects on other anxiety or depression-related
phenotypes such as anxiety, depression or on different personality
traits.
Two review authors (MTE and FNM) independently selected
studies for possible inclusion in the study. Firstly, titles and
abstracts identified from the search were independently reviewed.
Secondly, each review author independently examined the full text
of all studies that they considered to be of possible relevance. Each
review author compiled a list of studies that they believed met the
inclusion criteria. The content of each review author’s list was
compared and any discrepancies discussed. Any disagreement was
resolved by discussion and a consensus was reached by all authors.
Data extraction
Two investigators (FNM and MTE) independently extracted
data using a standardized data extraction form and they were
entered into separate databases by each of the reviewers
independently following standardized procedures. In case of
disagreement, a consensus was reached by the reviewers. Where
more than one psychiatric disorder was described in a particular
study, only data from the PTSD sample were extracted.
Therefore, in the case of multiple papers from a single study,
only the results of the publication with the highest number of
participants were included, since the unit of analysis was the study
rather than the reports to avoid duplicity. When essential data
were missing from the study report, the corresponding author was
contacted and asked to provide the required data.
Information on the data extraction form included: author(s),
journal and year of publication; methodology details (study design,
sample size for both cases and controls, diagnostic tools for
determination of case status and definition of case status); and
sample characteristics (gender ratio, mean age, ethnic background,
Hardy-Weinberg Equilibrium (HWE) in controls, genotype and
allele frequencies when appropriate, type of trauma event, time
from trauma exposure, severity of PTSD, other mental health
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disorders, including comorbid substance abuse and suicide-related
behaviors).
Quality of the studies
As poor reporting quality has been associated with a biased
estimation of effects in clinical intervention studies [25], the quality
of each study selected for inclusion was assessed by applying a 12-
item quality checklist, derived from the STREGA statement
(Strengthening the Reporting of Genetic Association Studies) [26]
and other criteria [24,27,28]. Specifically, the quality criteria were:
(1) representativeness of cases; (2) representativeness of controls; (3)
same PTSD diagnostic instrument used for cases and controls; (4)
trauma-exposed controls; (5) identical trauma exposure for cases
and controls; (6) assessment of ethnicity; (7) blind assessment of
genotyping and phenotyping; (8) quality control procedures for
genotyping methods; (9) HWE testing; (10) adjustment for
potential confounding variables; (11) control for multiple compar-
isons and (12) assessment of psychiatric comorbidity. A quality
score of one was assigned if the criteria were correctly assessed and
the Total Quality Score (TQS) of each study was calculated by
adding all the corresponding quality item scores (range: 0–12 with
a higher score indicating a higher overall quality). Discrepancies in
the quality evaluation of each study were resolved by consensus.
Consistent with current guidelines, we did not weight studies by
TQS or exclude studies with low-quality scores.
Statistical analysis
Inter-rater agreement was measured by Cohen’s kappa
coefficient for inclusion and exclusion criteria. The association
between the 5-HTLLPR allelic frequency and PTSD was
examined by statistical analyses, firstly using the biallelic model
(Biallelic Frequency Model, BFM) and then a triallelic one
(Triallelic Frequency Model, TFM) by calculating the respective
Odds Ratio (OR) and its corresponding 95% confidence interval
(95% CI) as the effect size measurement for these analyses. The
triallelic model was used whenever the original researchers
provided the frequencies of S’ (as the sum of the frequencies of
LG and S) and the frequency of L’ (LA). However, as the type of
inheritance of the 5-HTTLPR polymorphism was not yet known,
two more ORs were calculated per study and model, the first one
reflecting the risk of PTSD associated with possessing at least one S
or S’ allele (Biallelic or Triallelic Dominant Model, BDM or
TDM, respectively) and the second one reflecting the risk of
association with two S or S’ alleles (Biallelic or Triallelic Recessive
Model, BRM or TRM respectively). ORs were calculated for each
study so that an OR of greater than one reflected a higher risk for
PTSD. To assess the possible differences between a biallelic or a
triallelic model and due to the non-independent nature of the
studies compared, a qualitative comparison of the results was
performed on those studies which had data for both models in the
same sample.
Random-effects models were applied in the statistical analyses
because heterogeneity among the studies was expected. This
assumes a genuine diversity in the results of the various studies and
it incorporates a between-studies variance into the calculations. In
each meta-analysis, a pooled OR and its corresponding 95% CI
were calculated. In addition, the statistical significance of the
pooled OR was assessed using the Z test [29]. A sensitivity analysis
was performed to assess whether our results were substantially
influenced by the presence of any individual study by systemat-
ically removing each study and recalculating the significance of the
result.
Forest plots were constructed to represent the individual and
pooled effect estimates, with their 95% CIs, and to allow visual
inspection for study heterogeneity. To check for this among the
studies, both the Cochran’s Q-statistic and I2 index were
calculated [30]. When the ORs are homogeneous, Q-statistic
follows a chi-squared distribution with k – 1 degrees of freedom
(d.f.) (k being the number of studies). The degree of heterogeneity
was estimated with the I2 index (I2 = 1006(Q–d.f.)/Q), which can
be interpreted as the percentage of total variation across the
studies due to their different characteristics. I2 values around 25%,
50%, and 75% denote low, moderate and large heterogeneity,
respectively.
To explore heterogeneity, different subgroup analyses, which
allow chi-squared tests for between group differences, were
performed taking as potential moderators the quality items,
ethnicity and study design. In addition, meta-regression analyses
were carried out with continuous moderators, such as the mean
age of participants, the TQS, percentage of males, year of
publication, percentage of Caucasian or Euro-Americans and
percentage of Afro-Americans or Africans to test potential
explanatory variables leading to heterogeneity.
Chi-squared tests were conducted to test for HWE in the
reported genotype frequencies among the controls in case-control
and cross-sectional studies and among the whole population in the
cohort studies. Deviations from HWE (P-value ,0.05) might
indicate genotyping errors, limited population size, population
substructure or newly occurring mutations. No deviation from
HWE is considered a quality measure of a genetic association
study and a subgroup analysis was performed to compare those
studies with and without HWE.
To assess whether publication bias may be a threat to the
validity of the pooled ORs, funnel plots with the Duval and
Tweedie’s trim-and-fill method [31] were applied, as well as the
Egger test [32]. Where funnel plot asymmetry was observed, effect
estimates corrected for small study effects, such as publication bias,
were generated by the trim-and-fill method. This uses available
data to estimate the number and outcome of missing (unreported)
studies and recalculates the overall effect that would be observed
with their inclusion. The Egger test is an unweighted regression
consisting of taking the precision of each study as the independent
variable (precision being defined as the inverse of the standard
error of each effect size) and the effect size divided by its standard
error as the dependent variable. A non-statistically significant
result of the t-test for the hypothesis of an intercept equal to zero
allows discounting of publication bias as a threat to the validity of
the pooled effect [32].
All statistical tests were interpreted assuming a significance level
of 5% (a= 0.05) and all were two-tailed. The main statistical
analyses were carried out using the software package RevMan
5.029. Meta-regressions, funnel plots with the trim-and-fill method
and the Egger test were calculated with the program Comprehensive
Meta-analysis 2.0 [33]. Methods of the analysis and inclusion-
exclusion criteria were specified a priori and documented in a
protocol. The published recommendations for systematic reviews
of genetic association studies were followed [24,27,34]. Since we
only used previously published data, we did not consider it
necessary to seek ethical approval or written informed consent.
Results
Figure 1 details the search process flow and results. From a total
of 25 potentially eligible studies, seven were excluded because they
were a case or case-series design [35–37] or were focused on other
phenotypes apart from PTSD [38–41]. Cohen’s kappa inter-rater
agreement coefficient for the three inclusion criteria ranged from
0.70 (criterion 3) to 1.0 (criteria 1 and 2) and 0.905 for the
5-HTTLPR and Post-Traumatic Stress Disorder
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exclusion criteria. From the 18 studies eligible for inclusion, three
were excluded as they were based on the same sample ([12,42] and
[43]) as the final included studies ([16] and [44]), respectively.
Fifteen studies were included in the review and their data were
extracted [16–21,45–50]. An additional study was sent by the
corresponding author who was contacted for further information
about a published study. By the time this meta-analysis was
performed, this study was accepted for publication and, therefore,
included in this review [51]. Three studies were excluded as
essential data on 5-HTTLPR genotypic frequencies could not be
provided by the authors [44,52,53]. Finally, 13 studies were
included in the meta-analysis.
The characteristics of studies eligible for inclusion are described
in Table 1, including year of publication, study design, number of
PTSD cases, controls and total sample, number and percentage of
males, mean age, diagnostic instrument used to assess PTSD, type
of PTSD assessed, biallelic or triallelic genotype approach,
whether a GxE interaction had been analyzed and a brief
description of the environment studied and of the final decision to
include or exclude. The pooled population was 1,874 patients with
PTSD and 7,785 controls in the biallelic meta-analysis and 627
and 3,524, respectively, in the triallelic one.
Originally, six studies [17,18,46–48,51] described a biallelic
analysis and seven [16,19–21,45,49,50] a triallelic. Nevertheless,
five of the latter group [19,21,45,49,50] provided the frequencies
of the biallelic genotype so that they could also be included in the
meta-analysis of the biallelic approach (Table 2).
Meta-analysis of the allelic association with PTSD
Firstly, a meta-analysis of the biallelic approach was performed
for: i) allele frequency (S vs L) (Fig 2); ii) the dominant model, BDM
(S+vs LL) (Fig 3); and iii) the recessive model, BRM (SS vs L+) (fig 4).
The overall association between genotypes and the risk of PTSD
was not significant using all three different approaches: (i) OR
Figure 1. Flow chart of the Meta-Analysis of 5-HTTLPR polymorphisms and Post-traumatic Stress Disorder (PTSD). Adapted from Sagoo
GS, Little J, Higgins JP, Systematic Reviews of Genetic Association Studies. Human Genome Epidemiology Network. PLOS Med 2009; 6(3): e28 doi: e28
10.1371/journal.pmed.1000028 and Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097.
doi:10.1371/journal.pone.0066227.g001
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= 1.05; 95% CI = 0.87, 1.26; p = 0.63; I2 = 63; ii) OR = 1.01;
95% CI = 0.78, 1.30; p = 0.95; I2 = 57; and iii) OR = 1.15; 95%
CI = 0.82, 1.60; p = 0.41; I2 = 55, respectively) (Figs 2, 3 and 4).
Secondly, a meta-analysis of the triallelic approach offered
similar results for the TFM model (OR = 1.15; 95%CI = 0.82,
1.60; p = 0.41; I2 = 74), for TDM model (OR = 1.02; 95%CI
= 0.73, 1.48; p = 0.93; I2 = 43) and for the TRM (OR = 1.31; 95%
CI = 71, 2.41; p = 0.38; I2 = 80) (Figs 5, 6 and 7, respectively).
Comparison of the biallelic or triallelic models of the 5-
HTTLPR polymorphisms
Of the seven studies describing a triallelic approach, it was not
possible to calculate the biallelic frequencies of one of the studies
and we could not obtain further data from the authors on request
[16]. The biallelic frequencies of the second study [20] were
included in a different study when requested [51] and the
genotype frequencies from PTSD and controls could not be
calculated from the text as they only provided the total biallelic
frequencies. Finally, five studies [19,21,45,49,50] reported allele
and 5-HTTLPR polymorphism frequencies of the same population
allowing comparison of both approaches. The result were very
similar in the allele frequency model (BFM, OR = 1.07; 95% CI:
0.66, 1.74; I2 = 78% and TFM, OR = 1.14; 95% CI: 0.70, 1.87;
I2 = 81%), in the dominant model (BDM, OR = 1.09; 95% CI:
0.61, 1.96; I2 = 72%, TDM, OR = 0.93; 95% CI: 0.60, 1.44; I2
= 39%) and in the recessive model (BRM, OR = 1.05; 95% CI:
0.41, 2.67; I2 = 73%, TRM, OR = 1.40; 95% CI: 0.54, 3.57;
I2 = 85%).
Sensitivity analysis
Only one study [19] was found to alter the results when
individually removed from the meta-analysis during sensitivity
analysis and it affected the TFM model (OR = 1.31; 95% CI
= 1.06, 1.63; p = 0.01; I2 = 35). The remaining results were robust
to sensitivity analysis, with the overall P-values remaining non-
significant when each study was individually removed from the
analysis. Analysis of heterogeneity varied from moderate (I2 = 43
in TDM) to extreme (I2 = 80 in TRM) in the different models.
Publication bias
In order to assess whether publication bias might be a threat to
the pooled ORs, several graphical and analytic techniques were
applied. Firstly, funnel plots were constructed and the trim-and-fill
method proposed by Duval and Tweedie was applied to them in
Table 2. Frequencies of the 5-HTTLPR alleles and polymorphisms of the included studies&.






S L SS SL LL S L SS SL LL S’ L’ S’S’ S’L’ L’L’ S’ L’ SvS’S’LvLvL’
Lee
[18]
2005 175 25 77 21 2 319 75 129 61 7 0.81 – – – – – – – – – – –
Koenen
[16]
2009 – – – – – – – – – – – 17 21 4 9 6 539 603 116 307 148 0.06
Mellman
[21
2009 42 70 5 32 19 35 93 7 21 36 0.16 66 46 20 26 10 67 61 18 31 15 0.81
Xie
[20]
2009 – – – – – – – – – – – 234 224 58 118 53 957 1089234 489 300 0.20
Grabe
[19]
2009 40 94 6 28 33 12941898 264 766 566 0.86 48 86 8 32 27 1512 1680364 784 448 0.55
Thakur
[47]
2009 23 25 8 7 9 22 12 7 8 2 0.09 – – – – – – – – – – –
Kolassa
[17]
2010 112 550 15 82 234 29 125 1 27 49 0.20 – – – – – – – – – – –
Saying
[48]
2010 30 28 6 18 5 41 55 6 29 13 0.045 – – – – – – – – – – –
Koenen
[50]
2011 10 34 1 8 13 45 103 12 21 41 0.005 21 23 4 13 5 67 81 17 33 24 0.39
Morey
[49]
2011 22 22 7 8 7 18 22 3 12 5 0.34 26 18 10 6 6 22 18 5 12 3 0.34
Valente
[46]
2011 55 71 13 29 21 38 30 9 20 5 0.26 – – – – – – – – – – –
Wang
[45]
2011 207 217 56 95 61 131 221 21 89 66 0.28 261 163 94 73 45 164 188 29 106 41 0.005
Xie (AA)
[51]
2012 222 650 26 170 240 12693997 170 929 1534 0.07 – – – – – – – – – – –
Xie (EA)
[51]
2012 460 564 96 268 148 25113187 566 1379 904 0.34 – – – – – – – – – – –
S, short allele; L, long allele; S’ as S + LG; and L’ as LA.
&Dominant model (S+ vs LL or S’+vs L’L’): S+ (or S’+) genotype frequencies are calculated as the sum of SS (or S’S’) and SL (or S’L’) frequencies. Recessive model (SS vs L+
or S’S’ vs L’+): L+ (or L’+) genotype frequencies are calculated by the sum of LL (or L’L’) and SL (or SvL’) genotype frequencies.
doi:10.1371/journal.pone.0066227.t002
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order to achieve symmetry when they showed an asymmetric
pattern. Of the six funnel plots constructed, the trim-and-fill
method did not require the addition of any new effect estimate in
five of them to achieve symmetry (Fig 8). The only exception was
with the Biallelic Recessive model where the Duval and Tweedie’s
method added a new effect estimate. However, the adjusted
pooled OR (OR = 1.10; 95% CI: 0.79, 1.54) showed a negligible
difference from the original pooled OR (OR = 1.14; 95% CI:
0.81, 1.59). In addition, the Egger test was applied to each of the
six meta-analytic databases, in all cases achieving a non-
statistically significant result for the intercept of the regression
model (p.0.05) (Table 3). Therefore, on the basis of this, we felt
that we could reasonably discount publication bias as a threat to
our meta-analytic findings.
Quality of the studies
Table 4 describes the quality characteristics of the studies
analyzed. Included studies (N = 13) had a superior TQS (mean
= 6.31, SD = 2.428) than those excluded studies (N = 3; mean
= 1.33; SD = 1.528) (p = 0.005). The TQS of those studies with a
biallelic approach (N = 6; mean = 4.17, SD = 1.329) was
significantly lower than of those with a triallelic approach (N = 7;
mean = 8.14; SD = 1.345) (p,0.001).
The subgroup analysis of the different quality components
(Tables 5 and 6) showed that there were some significant
differences in estimated effect size between those studies that
fulfilled the quality criteria and those that did not: the same
principal trauma for PTSD and controls (BFM and BRM),
reporting of HWE (BDM) and control for multiple comparisons
(BFM and BDM) in the biallelic analysis. In the triallelic analysis,
the significant differences were for the same principal trauma for
PTSD and controls (TFM and TRM), the presence of blind
assessment (TRM) and control for multiple comparisons (TFM
and TRM). Moreover, when stratifying for the quality criteria, the
pooled effect size of those that fulfilled them reached significance
(same principal trauma for PTSD and controls – BFM, BRM and
TRM – presence of blind assessment – TRM – and control for
multiple comparisons – BFM, TFM and TRM -). On the other
hand, there was one characteristic where not fulfilling the quality
criteria significantly decreased the risk, i.e. those studies which did
Figure 2. Forest plot of the 5-HTTLPR biallelic frequency model (S vs L) and Post-traumatic Stress Disorder (PTSD).
doi:10.1371/journal.pone.0066227.g002
Figure 3. Forest plot of 5-HTTLPR biallelic dominant model (S+ vs LL) and Post-traumatic Stress Disorder (PTSD).
doi:10.1371/journal.pone.0066227.g003
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not use the same diagnostic instrument for PTSD and controls
(BFM and BRM) (Tables 5 and 6).
The subgroup analysis of study design and the type of PTSD
assessed revealed significant differences between study design in
TFM and TRM and between types of PTSD assessed (TFM and
TRM). The pooled risk effect of cohort studies and restriction of
the analysis to current PTSD significantly increased the risk in
those carrying S’ (TFM) or S’S’ (TRM) (Table 6).
Four studies did not calculate HWE (Table 4) but, when we
calculated it (Table 2), two of them were in HWE [16,21] and the
rest were not [48,50]. Another study was only in HWE in the
biallelic approach but not in the triallelic one [45]. Given these
discrepancies, we performed a subgroup analysis with our
calculated HWE and there were significant differences in the
triallelic analysis between those studies in HWE when compared
to those without in the TFM (OR = 1.00; 95% CI = 0.76, 1.32;
I2 = 53 and OR = 1.84; 95% CI = 1.38, 2.44; I2 = Not applicable,
respectively, p-value of the Chi-squared test for subgroup
difference = 0.003) and in TRM (OR = 1.02; 95% CI = 0.69,
1.51; I2 = 34 and OR = 4.04; 95% CI = 2.49, 6.54; I2 = Not
applicable, respectively, p-value of the Chi-squared test for
subgroup difference ,0.0001).
Meta-regression analysis (Table 7) showed modifying effects of
four variables, two of them in the direction of decreasing the risk of
the S’+ on PTSD (the median age of participants –TDM- and the
percentage of European or Caucasian -TDM-) and the other two
increasing the effect of S’+ on PTSD (the percentage of Afro-
Americans or Africans – TDM -) and that of S’S’ (TQS – TRM -).
No significant association with other pre-specified moderator
variables was identified.
Gene-Environmental (GxE) Interactions
Only six included studies analyzed GxE interactions
[16,17,19,20,50,51] (Table 1). The environments studied were
those of high crime and high unemployment rates [16], adult
traumatic events [20], childhood adversities [20,51] and number
of traumatic events experienced [17,19,50]. Four studies detected
a significant GxE interaction, three of them with the S or S’ allele
interacting with the environment [16,20,51] and the fourth
described an additive GxE interaction with the L’ (LA) allele
[19]. Interestingly, the GxE interaction effect, with childhood
adversity as the modifying variable, was only described in
European Americans but not in Afro-Americans [20,51]. Two
studies did not find a significant GxE interaction for 5-HTTLPR
Figure 4. Forest plot of 5-HTTLPR biallelic recessive model (SS vs L+) and Post-traumatic Stress Disorder (PTSD).
doi:10.1371/journal.pone.0066227.g004
Figure 5. Forest plot of 5-HTTLPR triallelic frequency model (S’ vs L’) and Post-traumatic Stress Disorder (PTSD).
doi:10.1371/journal.pone.0066227.g005
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genotype [17,50]. The low number of studies of each different
environment did not permit a meta-analysis.
Discussion
To our knowledge, this is the first published meta-analysis of the
relationship between 5-HTTLPR polymorphisms and PTSD. We
found no significant relationship between biallelic or triallelic
polymorphism and PTSD, using the three possible approaches
(allele frequency, dominant and recessive model). Contrary to
expectation, the triallelic approach (S’ and L’) did not appear to
alter the results of the meta-analysis obtained by the biallelic
approach (S and L). There was no apparent publication bias but
there was great variability in TQS and in some individual quality
characteristics of the included studies. For example, there was a
significant main effect when the analysis was restricted to those
studies measuring current PTSD (BRM, TFM and TRM) and a
significant effect in cohort studies was apparent in TFM and
TRM, the study design which is less prone to bias than case-
control and cross-sectional ones. Finally, several potential moder-
ators were detected in the meta-regression analyses (mean age of
participants, ethnic distribution of the population studied and the
TQS) and these significantly modified the results. These results
suggest that when more homogeneous groups within studies are
considered, thus fulfilling these criteria, potential evidence that
PTSD is associated with 5-HTTLPR may indeed emerge and this
warrants further research.
There has recently been increasing interest in developing
guiding principles for reporting results of different study designs in
order to improve the quality of research reports. The STrength-
ening the REporting of Genetic Association studies (STREGA)
Statement was published in 2009 [26] as an extension of the
Strengthening the Reporting of Observational Studies in Epide-
miology (STROBE) [54] and was specifically designed to enhance
the transparency of the reports of genetic association studies.
Interestingly, none of the seven studies published since then
[17,45,46,48–51] has followed these recommendations.
One possible consequence of our results might be that PTSD is
not directly associated with 5-HTTLPR. However, several other
reasons need to be considered to explain the absence of a
significant effect of the 5-HTTLPR on PTSD, given the increasing
evidence suggesting the implication of the 5-HTTLPR polymor-
phisms and different psychopathological conditions related to
stress sensitivity [5]. Firstly, published work in this research area
has only considered a third functional allele in the 5-HTTLPR
polymorphisms. Our findings do not support significant differences
between the biallelic and the triallelic analyses. Nevertheless, at
least ten allelic variants have been described in 5-HTTLPR
polymorphisms in humans [13] and it is not clear whether the
magnitude of any association may be affected or moderated by this
variability.
Secondly, the lack of a significant association may be due to
limited statistical power. Emerging evidence from large genetic
studies of other mental disorders suggest the individual effect size
of specific alleles may be very small with disorders which are
Figure 6. Forest plot of 5-HTTLPR triallelic dominant model (S’+ vs L’L’) and Post-traumatic Stress Disorder (PTSD).
doi:10.1371/journal.pone.0066227.g006
Figure 7. Forest plot of 5-HTTLPR triallelic recessive model (S’S’ vs L’+) and Post-traumatic Stress Disorder (PTSD).
doi:10.1371/journal.pone.0066227.g007
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highly polygenic [55]. Consistent with this, findings of other meta-
analyses of the same genetic factor with different phenotypes have
found a small association. For example, the pooled OR for the S
allele and unipolar depression is 1.08 (95% CI = 1.03, 1.12) [56],
1.12 (95% CI = 1.03, 1.21) for bipolar disorder [57] and 1.18
(95% CI = 1.02, 1.33) for alcohol dependence [58]. In our meta-
analysis, twelve studies were included in the biallelic model with
1,874 PTSD cases but only seven were included in the triallelic
with 627 PTSD cases. Therefore, if we consider the different study
designs and types of PTSD assessed, it is reasonable to consider the
possibility of a lack a statistical power as necessary to detect a true
relationship between 5-HTTLPR and PTSD. If this is the case,
new association studies with larger samples are necessary and
further meta-analyses should be performed in future to detect a
more accurate estimation of a true effect. Another example is
related to population stratification. Interestingly, the first published
study [18] was performed in an Asian population and has not been
replicated and all studies published since have been performed in
Caucasian or African or Afro-American populations. As differ-
ences in ethnic distribution have been described [8,11,13,16],
population stratification should be controlled or stratified in future
studies.
Thirdly, 5-HTTLPR might not have a primary direct effect on
PTSD. As PTSD diagnosis requires exposure to an environmental
stressor, it is an ideal condition for the investigation of GxE
interactions, where the effects of environmental exposure are
moderated by genotype [4,59]. However, only six studies have
formally tested GxE interactions in this field [16,17,19,20,50,51].
So far, the low number of studies and the high variability of
stressors analyzed do not allow formal meta-analyses of these
interactions. On the other hand, there may be other interactions
underlying the potential role of specific genes in the etiology of
PTSD. For example, a gene-gene interaction might also explain
the absence of a main genetic effect in PTSD as has been
described in neuroticism, where BDNF Val66Met interacts with 5-
HTTLPR to influence neuroticism [60]. It is also possible that the
relationship between the 5-HTTLPR genotype and PTSD could
be mediated by other personality traits as has been suggested in the
case of neuroticism as a mediator of the association of the 5-
HTTLPR polymorphism with lifetime major depression [61].
Finally, epigenetic modification offers a promising research area
that may clarify the variability of the results obtained in PTSD
Figure 8. Funnel plots of 5-HTTLPR polymorphisms and Post-traumatic Stress Disorder (PTSD) to assess publication bias. White
circles represent each of the included studies. Black circles represent the new effect estimated to achieve symmetry.
doi:10.1371/journal.pone.0066227.g008
Table 3. Analyses of publication bias by the Egger test.
Model Intercept SE T df p-value
Biallelic
BFM 20.319 0.857 20.371 10 0.718
BDM 20.658 0.721 20.912 10 0.383
BRM 0.273 0.763 0.358 10 0.727
Triallelic
TFM 20.842 1.738 20.484 5 0.648
TDM 20.775 1.160 20.668 5 0.534
TRM 20.625 2.010 20.311 5 0.768
SE: Standard error; T: T-test; df: Degrees of freedom. BFM: Biallelic Frequency
Model; BDM: Biallelic Dominant Model; BRM: Biallelic Recessive Model; TFM:
Triallelic Frequency Model; TDM: Triallelic Dominant Model; TRM: Triallelic
Recessive Model.
doi:10.1371/journal.pone.0066227.t003
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Table 5. Subgroup analysis of study design, type of PTSD assessed and quality characteristics in the Meta-Analysis of 5-HTTLPR




# Dominant Model Recessive Model
OR 95%CI I2(%) P-value & OR 95%CI I2 (%) P-value & OR 95%CI I2 (%) P-value &
Case representativeness
Yes 1 96 0.67 0.31, 1.48 NA 0.86 0.33, 2.26 NA 0.25 0.03, 2.01 NA
No 11 9563 1.07 0.88, 1.26 63 0.27 1.02 0.78, 1.32 61 0.75 1.18 0.81, 1.65 56 0.15
Control representativeness
Yes 8 2835 1.01 0.72, 1.43 70 0.98 0.86, 1.38 65 1.20 0.62, 2.30 50
No 4 6824 1.06 0.88, 1.28 54 0.82 1.09 0.86, 1.38 39 0.66 1.03 0.77, 1.39 40 0.68
Same diagnostic instrument
Yes 11 9362 1.01 0.84, 1.22 63 0.99 0.77, 1.29 61 1.07 0.74, 1.53 54
No 1 297 1.65 1.01, 2.68 NA 0.07 1.81 0.37, 8.85 NA 0.47 1.76 1.02, 3.06 NA 0.13
Trauma exposed control
Yes 9 2932 0.96 0.69, 1.33 70 0.89 0.57, 1.39 66 1.12 0.62, 2.02 57
No 3 6727 1.09 0.94, 1.26 38 0.47 1.15 0.99, 1.32 0 0.28 1.08 0.76, 1.51 56 0.90
Same principal trauma for PTSD and controls
Yes 2 430 1.57 1.19, 2.06 0 1.38 0.90, 2.12 2 2.65 1.58, 4.44 0
No 10 9229 0.98 0.81, 1.26 63 0.005 0.96 0.72, 1.27 61 0.17 0.97 0.74, 1.26 20 0.0007
Assessment of ethnicity
Yes 10 9485 1.07 0.88, 1.29 65 1.04 0.81, 1.33 57 1.15 0.79, 1.67 62
No 2 174 0.93 0.40, 2.14 72 0.75 0.77 0.15, 3.87 76 0.72 1.06 0.43, 2.59 25 0.87
Presence of blind assessment
Yes 2 429 0.98 0.31, 3.02 83 0.69 0.11, 4.29 78 1.57 0.45, 5.53 70
No 10 9230 1.01 0.85, 1.20 52 0.95 0.99 0.76, 1.28 56 0.70 1.02 0.76, 1.36 29 0.51
Reporting of quality control procedures in genotyping methods
Yes 4 2267 1.05 0.60, 1.83 84 1.15 0.60, 2.22 78 0.89 0.31, 2.56 77
No 8 7392 1.04 0.89, 1.22 35 0.99 0.98 0.76, 1.27 41 0.66 1.09 0.83, 1.43 24 0.71
Reporting HWE{
Yes 9 9366 1.01 0.82, 1.24 69 0.92 0.71, 1.20 60 1.18 0.81, 1.71 64
No 3 293 1.23 0.76, 2.00 39 0.46 1.64 0.85, 3.17 33 0.11 0.90 0.34, 2.37 27 0.61
Adjustment for potential confounders
Yes 7 8774 1.09 0.88, 1.35 70 1.16 0.38, 1.03 59 1.04 0.67, 1.60 67
No 5 885 0.92 0.60, 1.41 57 0.48 0.63 0.38, 1.03 14 0.03 1.39 0.82, 2.35 20 0.40
study design. In addition, meta regres
Yes 3 550 1.57 1.23, 2.01 0 1.60 0.97, 2.63 31 1.95 0.93, 4.07 38
No 9 9109 0.94 0.87, 1.14 56 0.001 0.89 0.67, 1.16 55 0.04 0.98 0.73, 1.31 33 0.09
Psychiatric comorbidity assessed
Yes 9 8913 1.05 0.86, 1.29 66 1.08 0.83, 1.40 59 1.07 0.73, 1.56 58
No 3 746 0.97 0.53, 1.78 69 0.81 0.70 0.30, 1.62 36 0.34 1.57 0.87, 2.83 11 0.26
Study design
Cross-Sectional 5 8597 0.94 0.78, 1.12 52 0.94 0.73, 1.21 58 0.87 0.64, 1.17 23
Case-Control 5 944 1.32 0.93, 1.86 56 1.20 0.63, 2.28 60 1.61 0.97, 2.66 45
Cohort 2 118 0.89 0.32, 2.49 71 0.22 0.69 0.09, 5.26 75 0.75 1.16 0.46, 2.91 6 0.12
Type of PTSD assessed
Lifetime PTSD 7 8794 0.99 0.83, 1.19 50 1.04 0.74, 1.36 61 0.90 0.71, 1.14 8
Current PTSD 4 824 1.24 0.80, 1.93 66 0.93 0.43, 2.02 56 1.79 1.06, 3.01 45
Last year 1 41 0.50 0.20, 1.24 NA 0.21 0.22 0.04, 1.21 NA 0.21 0.71 0.20, 2.58 NA 0.06
`K: Number of studies; #Number of alleles S or L duplicates the number of participants as each participant has two alleles (S, L or one of each one); OR: Odds Ratio; 95%
CI: 95% Confident Interval; & Chi-squared test for subgroup differences; NA: Not applicable; {HWE: Hardy-Weinberg Equilibrium.
doi:10.1371/journal.pone.0066227.t005
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research as well as in other psychiatric illnesses [62]. There has
been an increasing interest in epigenetic factors in psychiatric
disorders and this involves the study of inheritable changes in gene
expression that occur without changes in the DNA sequence. The
level of methylation of 5-HTTLPR modified the effect of the
number of traumatic experiences on the risk of PTSD regardless of
the 5-HTTLPR polymorphisms [50] and it may explain how the
environment can modify gene expression regardless of the primary
genetic sequence by changing the accessibility of information
printed on the DNA [63].
We acknowledge some limitations of this meta-analysis in
relation to interpretation of the findings. Some studies could not be
included in the final analysis because of incomplete data.
However, it is unlikely that their inclusion would have affected
our main results due to the small sample size and their lower
quality characteristics. Errors or bias in the design of or in the
statistical tests in the primary observational studies could
potentially affect the results of our meta-analysis. Although 61%
of the included studies performed a controlled analysis for
potential confounding variables, our meta-analyses were per-
formed using the crude OR as the diversity of confounding
variables did not allow the use of the adjusted OR. Although this is
a general limitation of meta-analysis in observational studies,
careful analyses of the individual quality aspects and the different
study designs of the primary studies were performed to explore the
moderate/large levels of heterogeneity detected.
Of particular concern is the heterogeneity resulting from the
varying ethnic distribution within studies and its potential
confounding effect on the pooled effect size. To analyze this
particular aspect, different approaches were considered including
a subgroup analysis of the assessment of ethnicity and specific
meta-regression analyses of the effect of the percentage of different
ethnic groups (European/Caucasian or Afro-Americans/Africans).
Our results suggest that this ethnic distribution should be
considered as an important modifying variable in future research.
On the other hand, several strengths of our meta-analysis
deserve recognition. Firstly, although a TQS was calculated and
used in the meta-regression analyses, the relevant methodological
aspects were assessed individually and the influence on the
magnitude of the effect was explored as the TQS (as a summation
of points) giving equal weight to all characteristics [28]. Secondly,
we analyzed three inheritance models, as it was not yet clear which
one better represents the association between the 5-HTTLPR
poylymorphisms and PTSD as well as performing two allelic
studies (biallelic and triallelic). Given that there was little variation
according to the model or the approach studied, this supports our
view that our findings are indeed robust. Finally, we have followed
current guidelines for design and reporting of systematic reviews of
genetic association studies [24,27,34]. Nevertheless, these guide-
lines should be adapted to the specific characteristics of psychiatric
genetics as has recently been suggested for the adaptation of the
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) guidelines [64] to be used in psychiatric epidemiology
[65].
Implications
Although current evidence does not support a direct main effect
of the 5-HTTLPR polymorphisms on PTSD, GxE interactions and
epigenetic modulation offer promising research areas in the near
future. Further studies of possible genetic associations between 5-
HTTLPR and PTSD are needed to clarify this relationship and the
role of the potential moderators detected. Special attention should
be paid to some characteristics specifically in relation to PTSD
research, including exposure of controls to the same stressor as
Table 7. Meta-regression analysis of potential modifying variables in the Meta-Analyses of 5-HTTLPR polymorphisms and Post-
traumatic Stress Disorder (PTSD).
Frequency Model Dominant Model Recessive Model
bj 95%CI p-value bj 95%CI p-value bj 95%CI p-value
Year of publication
Biallelic approach 20.0521 20.1764, 0.0723 0.41 20.0728 20.3205, 0.1749 0.56 20.0132 20.2193, 0.1928 0.90
Triallelic approach 0.2077 20.0769, 0.4924 0.15 0.0550 20.3532, 0.4631 0.79 0.4648 20.0054, 0.9351 0.50
Males (%)
Biallelic approach 0.0094 20.0227, 0.4140 0.57 0.0042 20.0440, 0.0524 0.86 0.0346 20.0175, 0.0868 0.19
Triallelic approach 0.0007 20.0431, 0.0445 0.97 20.0124 20.0639, 0.0390 0.64 0.0167 20.0696, 0.1030 0.70
Mean Age
Biallelic approach 20.0110 20.0431, 0.0212 0.50 0.0046 20.0561, 0.0652 0.88 20.0315 20.1027, 0.0397 0.39
Triallelic approach 20.0177 20.0516, 0.0162 0.31 20.0324 20.0582, 20.0065 0.01 20.0259 20.0964, 0.0446 0.47
European or Caucasian (%)
Biallelic approach 20.0048 20.0126, 0.0030 0.23 20.0072 20.0188, 0.0044 0.23 20.0045 20.0203, 0.0113 0.57
Triallelic approach 20.0039 20.0126, 0.0048 0.38 20.0102 20.0178, 20.0025 ,0.01 20.0018 20.0199, 0.0163 0.85
Afro-Americans and Africans (%)
Biallelic approach 0.0015 20.0066, 0.0096 0.72 0.0053 20.0060, 0.0166 0.36 0.0002 20.0158, 0.0162 0.98
Triallelic approach 0.0035 20.0052, 0.0123 0.43 0.0110 0.0033, 0.0187 0.005 20.0004 20.0180, 0.0172 0.96
Total Quality Score (TQS)
Biallelic approach 0.0120 20.0483, 0.0723 0.70 0.0175 20.0666, 0.1017 0.69 0.0418 20.0605, 0.1440 0.42
Triallelic approach 0.1484 20.0670, 0.3638 0.18 0.0113 20.2636, 0.2863 0.94 0.3518 0.4017, 0.6619 0.03
bj: regression coefficient for the moderator variable; 95% CI: 95% Confident Interval.
doi:10.1371/journal.pone.0066227.t007
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PTSD cases, type of PTSD assessed, psychiatric comorbidity and
population stratification. These new studies, in addition to those
already published on the effect of GxE interactions and on new
potential environmental factor candidates to interact with the 5-
HTTLPR polymorphisms, may help to clarify the role of this and
other genetic factors in PTSD.
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